Fate Therapeutics Inc Funding Round - Series B 2009

Financial Transaction:

Series B

Fate Therapeutics Inc

Round participants

Investor		Country	Notes
	ARCH Venture Partners LP Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup	United States	Follow-on investment.
	Astellas Venture Management LLC	United States	Initial investment.
	Genzyme Corp	United States	Initial investment.
	OVP Venture Partners (Olympic Venture Partners)	United States	Follow-on investment.
	Polaris Venture Partners Inc Multistage venture capital investors with focus Technology, Healthcare and Consumer	United States	Follow-on investment.
	Venrock Associates The venture capital arm of the Rockefeller Family.	United States	Follow-on investment.